Versant Capital Management’s Maze Therapeutics MAZE Stock Holding History
Bought
Maintained
Sold
Other funds holding MAZE
Versant Capital Management's MAZE Position: Q3 2026 in Review
Versant Capital Management opened a new position in Maze Therapeutics (MAZE) in Q3 2026: 202 shares worth $5.49K. The stake represents ﹤0.01% of the portfolio and ranks #2437 among its holdings.
158 funds tracked by Wall St. Rank hold MAZE as of Q3 2026.
- Versant Capital Management held 202 shares of Maze Therapeutics worth $5.49K as of Q3 2026.
- Maze Therapeutics was a new Versant Capital Management position in Q3 2026.
- Maze Therapeutics made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2437 holding.
- 158 funds tracked by Wall St. Rank held Maze Therapeutics as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.